Status | Study |
Recruiting |
Study Name: PT2385 for the Treatment of Von Hippel-Lindau Disease-Associated Clear Cell Renal Cell Carcinoma Condition: VHL Gene Mutation VHL VHL Syndrome Date: 2017-03-28 Interventions: Drug: PT2385 Tablets PT2385 inhibits HIF-2α and is a novel approach to treatment of VHL disease-ass |
Recruiting |
Study Name: Familial Investigations of Childhood Cancer Predisposition Condition: Acute Leukemia Adenomatous Polyposis Adrenocortical Carcin Date: 2017-02-08 |
Recruiting |
Study Name: Trial of Sirolimus for Cognitive Impairment in Sturge-Weber Syndrome Condition: Sturge-Weber Syndrome Date: 2017-02-02 Interventions: Drug: Sirolimus Low dose oral sirolimus Other Names: |
Recruiting |
Study Name: A Phase I/II Trial for Intravitreous Treatment of Severe Ocular Von Hippel-Lindau Disease Using a Combination of the PDGF Antagonist E10030 and the VEGF Antagonist Ranibizumab Condition: Von Hippel-Lindau Syndrome Date: 2016-08-06 Interventions: Drug: Ranibizumab Intravitreal |
Recruiting |
Study Name: Screening for Endolymphatic Sac Tumours (ELSTs) in Von Hippel-Lindau (vHL) Patients Condition: Von Hippel-Lindau Disease Date: 2015-04-09 |
Recruiting |
Study Name: Lymphatic Anomalies Registry Condition: Lymphatic Malformation Generalized Lymphatic Anomaly (GLA) Date: 2015-03-17 |
Active, not recruiting |
Study Name: Cannabidiol Expanded Access Study in Medically Refractory Sturge-Weber Syndrome Condition: Sturge-Weber Syndrome Date: 2015-01-05 Interventions: Drug: Cannabidiol Initiation of treatment will begin with |
Enrolling by invitation |
Study Name: Assessment of Residual VHL Function in Tumors - Can it Predict the Patients' Individual Course of Disease? Condition: Von Hippel-Lindaus Disease Date: 2014-08-01 |
Active, not recruiting |
Study Name: Psychosocial Consequences of the Screening of Von Hippel Lindau Diseases for Patients Operated for a hémangioblastoma of Nervous Centrasl System Condition: Hemangioblastoma (HB) of the Central Nervous System (CNS) Date: 2014-04-16 Interventions: Other: evaluation of anxiety with psychosocial scales |
Enrolling by invitation |
Study Name: Effect of Vorinostat on Nervous System Hemangioblastomas in Von Hippel-Lindau Disease (Missense Mutation Only) Condition: Von Hippel-Lindau Disease Date: 2014-04-05 Interventions: Drug: Vorinostat |